EngTree
Manufacturing & process plants
Manufacturing & process plantsPharmaceutical Manufacturing

Pfizer Sandwich Site Manufacturing Investment

Sandwich, Kent, UK · 2019-Present (ongoing investments) · £10m (advanced continuous tablet manufacturing), £5m (paediatric medicines manufacturing)

The judgement call

Account-gated at launch

Despite the significant R&D site closure in 2011, Pfizer has continued to invest in manufacturing capabilities at Sandwich, demonstrating the site's enduring importance for production. - The £10 million investment in advanced continuous tablet manufacturing highlights a shift towards more efficient and agile production methods in the pharmaceutical industry. - The focus on paediatric medicines manufacturing addresses a critical need for specialized drug forms for younger patients. - The site remains a significant employer and contributor to the local economy, showcasing resilience and adaptation after major restructuring.

Key engineering challenges

Implementing advanced continuous manufacturing processes to improve efficiency and speed of new medicine development. - Expanding specialized manufacturing capabilities for paediatric medicines, which often require specific formulations and production methods. - Maintaining high regulatory standards and product quality during manufacturing upgrades. - Adapting existing facilities to accommodate new technologies and production lines.

Project facts

Client / owner
Pfizer
Lead contractor
Lead designers
Project type
upgrade | expansion
Scale
New advanced continuous tablet manufacturing process; expanded capabilities for paediatric medicines.
Disciplines
pharmaceutical engineering; process engineering; chemical engineering; mechanical; electrical
Standards & frameworks
GMP (Good Manufacturing Practices), MHRA regulations

Sources: Pfizer.com (https://www.pfizer.com/sandwich-uk) - DDW Online (Jul 2021, https://www.ddw-online.com/pfizers-manufacturing-investment-that-will-help-speed-up-new-medicine-development-12116-202107/) - PharmaTimes (Jun 2019, https://pharmatimes.com/news/pfizer_to_invest_5m_in_paediatric_medicines_1291978/) - Science.org (blog post on 2011 closure, https://www.science.org/content/blog-post/bad-news-pfizer-closes-site-sandwich)